• President: Yoshio Okada, M.D.
• Date: June 22 (Sat), 1996
• Venue: Yasuda Auditorium, The University of Tokyo, Tokyo

Topics

• ORAL SESSIONS
1. NEW VECTOR DEVELOPEPMENT
2. CELL TARGETING
3. GENE TARGETING
4. CLINICAL IMPLICATIONS
• POSTER SESSIONS

Program

• Oral Session(No. 1 - 26 )
1. Gene Transfer Technique I /
   Viral Vectors (09:00-10:00 am)
   Chairpersons: Hirofumi Hamada and Hiromitsu Nakauchi
2. Gene Transfer Technique II /
   AAV and Non-viral Vectors (10:00-11:12 am)
   Chairpersons: Keiya Ozawa and Takashi Shimada
3. Gene Transfer Techniques III /
   Gene Transfer to Hematopoietic Cells (11:12am-12:00 pm)
   Chairpersons: Tatsutoshi Nakahata and Toshio Suda

Poster Session (12:30-15:00 pm)

General Assembly(14:30-15:00 pm)

4. Gene Therapy for Genetic Diseases (15:00-15:36pm)
   Chairpersons: Toya Ohashi and Takashi Tsuruo
5. Gene Therapy for Cancer(15:36-16:36 pm)
   Chairpersons: Tetsuo Noda and Jun Yoshida
6. Gene Therapy for Other Acquired Disorders (16:36-17:12pm)
   Chairpersons: Hiroshi Shiku and Yasufumi Kaneda

• Poster Sessions ( No. 1 - 60 )
1. Gene Transfer Techniques (I)( No. 1 - 5 )
   Gene Transfer Into Hematopoietic Cells
2. Gene Transfer Techniques (2)( No. 6 - 16 )
   Viral Vectors
3. Gene Transfer Techniques (3)( No. 17 - 22 )
   Non Viral Vectors
4. Gene Therapy of Cancer (1) (No. 23 - 27 )
   Drug Sensitivity Genes
5. Gene Therapy of Cancer (2) (No. 28 - 39 )
   Cytokine Immuno-Gene Therapy
6. Gene Therapy of Cancer (3) (No. 40 - 45 )
   
7. Gene Therapy of Genetic Diseases ( No. 46 - 53 )
   
8. Gene Therapy of Other Diseases ( No. 54 - 60 )